ResMed Inc (RMD)
Total asset turnover
| Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 5,146,330 | 5,021,540 | 4,926,780 | 4,807,490 | 4,546,017 | 4,444,877 | 4,364,797 | 4,235,737 | 4,222,994 | 4,015,671 | 3,763,271 | 3,624,405 | 3,578,126 | 3,539,492 | 3,443,759 | 3,348,896 | 3,196,825 | 3,091,065 | 3,091,753 | 3,027,899 |
| Total assets | US$ in thousands | 8,174,390 | 7,566,820 | 7,141,330 | 7,222,420 | 6,872,390 | 6,814,560 | 6,905,090 | 6,740,790 | 6,751,710 | 6,713,880 | 6,676,100 | 5,177,560 | 5,095,850 | 4,905,260 | 4,734,740 | 4,729,170 | 4,728,120 | 4,585,720 | 4,572,860 | 4,620,840 |
| Total asset turnover | 0.63 | 0.66 | 0.69 | 0.67 | 0.66 | 0.65 | 0.63 | 0.63 | 0.63 | 0.60 | 0.56 | 0.70 | 0.70 | 0.72 | 0.73 | 0.71 | 0.68 | 0.67 | 0.68 | 0.66 |
June 30, 2025 calculation
Total asset turnover = Revenue (ttm) ÷ Total assets
= $5,146,330K ÷ $8,174,390K
= 0.63
The total asset turnover ratio of ResMed Inc. demonstrates a generally stable trend over the analyzed period from September 2020 to June 2025, with some fluctuations. Beginning at 0.66 in September 2020, the ratio increased gradually throughout 2020 and into 2021, reaching a peak of 0.73 in December 2021. This indicates that during this period, ResMed was able to generate higher sales revenue relative to its total assets, reflecting improved asset utilization.
From the first quarter of 2022, the ratio shows signs of stabilization, maintaining values primarily in the 0.70s range, with minor fluctuations. Notably, there is a sharp decline observed at the end of 2022, with the ratio dropping to 0.56 in December 2022, signaling a decline in efficient asset utilization and/or a reduction in sales relative to total assets during this period.
Following this trough, the ratio gradually recovers, reaching approximately 0.66 in March 2023 and consistently staying within the range of 0.63 to 0.67 through to September 2024. This recovery implies an improved efficiency in utilizing assets to generate sales. The ratio's slight upward movement towards the end of this period suggests a stabilization in operational performance.
Overall, the long-term trend indicates that ResMed's asset utilization has experienced periods of improvement and decline, with a notable dip at the end of 2022. The fluctuations may reflect changes in sales effectiveness, capital investment, or operational efficiency. The relatively steady ratios in subsequent periods suggest a cautious but consistent management of assets in relation to sales generation capabilities.
Peer comparison
Jun 30, 2025